CSBR — Champions Oncology Share News
0.000.00%
Last trade - 00:00- $92.07m
- $85.14m
- $56.94m
Brief: Champions Oncology Q3 Adjusted EPS USD 0.04
Cancer research firm Champions Oncology's Q2 revenue rises as bookings quality improves
Brief: Champions Oncology Q2 Adjusted EPS USD 0.06
Brief: Champions Oncology Q1 Adjusted EPS USD 0.02
Champions Oncology Inc reports results for the quarter ended April 30 - Earnings Summary
Champions Oncology Q4 revenue beats analyst expectations
Champions Oncology Inc expected to post a loss of 20 cents a share - Earnings Preview
RCS - Champions Oncology - Champions Launches Radiopharmaceutical Services
Champions Oncology Inc expected to post a loss of 1 cent a share - Earnings Preview
RCS - Champions Oncology - Champions Oncology Enhances Clinical Bioanalytical
Champions Oncology Inc reports results for the quarter ended October 31 - Earnings Summary
Champions Oncology Inc expected to post earnings of 1 cent a share - Earnings Preview
Champions Oncology Inc expected to post earnings of 1 cent a share - Earnings Preview
Champions Oncology Inc reports results for the quarter ended in April - Earnings Summary
Champions Oncology Inc expected to post a loss of 10 cents a share - Earnings Preview
Champions Oncology Inc reports results for the quarter ended in October - Earnings Summary
Brief: Champions Oncology Q2 adjusted EPS USD -0.15
Champions Oncology Inc expected to post a loss of 17 cents a share - Earnings Preview
RCS - Champions Oncology - Champions Oncology News Announcement